港股创新药ETF(159567)资产配置 |
|
|
| 报告日期 |
股票(元) |
债券(元) |
基金总资产(元) |
基金净值(元) |
股票占净值比 |
| 2026/3/31 |
7,493,900,000 |
- |
7,822,770,000 |
7,600,630,000 |
99% |
| 2025/12/31 |
7,718,750,000 |
- |
7,925,270,000 |
7,896,560,000 |
98% |
| 2025/9/30 |
7,514,870,000 |
- |
7,776,280,000 |
7,700,750,000 |
98% |
| 2025/6/30 |
2,615,390,000 |
- |
2,961,900,000 |
2,727,380,000 |
96% |
| 2025/3/31 |
668,795,000 |
- |
857,356,000 |
701,682,000 |
95% |
| 2024/12/31 |
367,400,000 |
- |
384,174,000 |
377,802,000 |
97% |
| 2024/9/30 |
188,480,000 |
- |
235,340,000 |
205,752,000 |
92% |
| 2024/6/30 |
129,070,000 |
- |
136,021,000 |
134,857,000 |
96% |
| 2024/3/31 |
133,017,000 |
- |
148,093,000 |
137,975,000 |
96% |
| 2024/1/4 |
60,593,100 |
- |
296,963,000 |
236,261,000 |
26% |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。